DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Biochemistry Analyzer Market 2017-2021" report to their offering.
The global Biochemistry Analyzer market to grow at a CAGR of 6.02% during the period 2017-2021.
The report, Global Biochemistry Analyzer Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
The latest trend gaining momentum in the market is modular design of biochemistry analyzer. The fully automatic biochemistry analyzer is used to analyze many biochemical parameters of blood sample like blood glucose, urea, protein, etc., to detect various diseases like kidney, liver, and other metabolic disorders. Therefore, by analyzing these parameters, the biochemistry analyzer helps in diagnosing various health disorders. It is a high performance-based micro-controller inbuilt with the photometric technology.
According to the report, one of the major drivers for this market is growing aging population. The increase in median age due to the reduction in fertility rate and the increase in life expectancy result in the growing aging population. These two demographic effects reflect the change in a country's population with a rising aging and a declining child population.
Key vendors
- Abbott
- Danaher
- Roche Diagnostics
-
Siemens
Other prominent vendors
- Abaxis
- Adaltis
- ELITech Group
-
Others
Key Topics Covered:
PART 01: Executive summary
PART 02: Scope of the report
PART 03: Research Methodology
PART 04: Introduction
PART 05: Market landscape
PART 06: Market segmentation by end-user
PART 07: Geographical segmentation
PART 08: Decision framework
PART 09: Drivers and challenges
PART 10: Market trends
PART 11: Vendor landscape
For more information about this report visit https://www.researchandmarkets.com/research/v5qf2j/global
